Global Pharmaceutical News

MIT researchers repurpose cancer compound to treat PKD I QUANTUNG PHARMA I www.quantung.com

Synendos receives EMA nod for brain therapy I QUANTUNG PHARMA I www.quantung.com

Serac to present data from DETECT study I QUANTUNG PHARMA I www.quantung.com

Stroke experts to test emerging nerve stimulation treatment I QUANTUNG PHARMA I www.quantung.com

UCB announces MHRA approval for UCB’s Zilbrysq I QUANTUNG PHARMA I www.quantung.com

Disco tunes into new cancer drug targets I QUANTUNG PHARMA I www.quantung.com

StemSight and ERS Genomics focus on collaboration I QUANTUNG PHARMA I www.quantung.com

Virtual reality training to help NHS doctors spot signs of sepsis I QUANTUNG PHARMA I www.quantung.com

NHS catch up campaign launched for missed MMR vaccines I QUANTUNG PHARMA I www.quantung.com

Poolbeg’s cytokine release syndrome drug shows potential I QUANTUNG PHARMA I www.quantung.com

Researchers advance blood tests’ ability to detect cancer earlier. The latest news on health and wellness, including the healthcare industry

NHS to test new blood group genotyping test on inherited blood disorder patients

Zydus Lifesciences on Thursday said it has received approval from the US health regulator

Researchers identify gene that causes heart defects in Down syndrome

PlaqueTec and Babraham Institute partner for treatment of coronary heart disease

Exclusive: Suspected fake Ozempic linked to three US cases of hypoglycemia

The FDA has approved the therapy based on data from the Phase III PROPEL pivotal study.

The latest development is based on data from Phase III ADVANCE and PROGRESS clinical trials.

Biomass will be used to meet particularly high energy demands, according to the German government's so-called "Easter Package", which aims t

UK MHRA approves AbbVie’s migraine prevention drug Aquipta. [Quantung Pharma – Quantung.com]